Atlas Trials

To Compare and Evaluate the Oral Bioavailability of Lisdexamfetamine 70 mg Capsule With That of Elvanse® 70 mg Capsules, Hard Lisdexamfetamine Dimesylate in Healthy, Adult, Human Subjects Under Fasting Conditions.

Clinical trial NCT07098585 · COMPLETED

Trial details

NCT number
NCT07098585
Sponsor
Humanis Saglık Anonim Sirketi
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Attention Deficit/Hyperactivity Disorder (ADHD)
Start date
2025-05-26
Primary completion
2025-06-06
Enrollment
48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.